87 results
8-K
EX-99.1
9wifd9jjejnc53e3h6e
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.2
16c5l5dm49satmz
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.1
k72d5ks
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
b9kn7mi8dy
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
EX-10.1
mbxer zwrku3bu4yigzq
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
424B5
f1smeazo
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
EX-10.1
lzg8fg55dfgz r7x
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am